Delivery Order SPE2DB20D2104-SPE2DB25FMRQM
Award Date
5/22/25
Potential Completion Date
6/13/25
Potential Value
$1.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award from the Defense Logistics Agency (DLA) was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of HYPERHEP B VIAL 5ML medical supplies. The $1,972.74 firm fixed-price delivery order has a completion date of November 21, 2023 and was awarded on October 30, 2022. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of HyperHEP B Vial 5mL medical products. The $2,243.10 firm fixed-price delivery order has a completion date of March 24, 2025 and was awarded on March 3, 2025. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support...
This federal contract award, identified as SPE2DB20D1109|SPE2DB23FP74Y, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $1,683.44, is for the delivery of HYPERHEP B VIAL 5ML, a medical product, with an ultimate completion date of September 6, 2023. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of HYPERRAB 300 UNIT/ML VIAL 5ML medical supplies. The $3,886.54 Firm Fixed Price Delivery Order was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency. The contract has an ultimate completion date of January 2, 2025 and was awarded on December 10, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a significant...
This federal contract award to Amerisourcebergen Drug Corp (a major pharmaceutical distributor) is a delivery order worth $2,657.33 for the supply of ENGERIX-B 20 MCG/ML SYRNML, a hepatitis B vaccine. The contract has an ultimate completion date of September 15, 2022 and was awarded on September 14, 2022 by the Defense Logistics Agency (DLA), a defense agency. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical,...
This federal contract award is for the delivery of HYPERRAB 300 UNIT/ML VIALML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $5,582.85 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, Corporate Office Division, a major pharmaceutical distributor, on June 13, 2024. The contract has an ultimate completion date of July 8, 2024 and was not set aside for any special designation. Amerisourcebergen holds a larger $999,999,999.00 Indefinite Delivery...
This federal contract award is for the delivery of TWINRIX vaccine syringes to the Defense Logistics Agency (DLA), a defense agency. The $4,281.54 firm fixed-price delivery order has a completion date of May 23, 2025 and was awarded on May 22, 2025 to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This delivery order is not set aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,002.16 firm fixed-price delivery order is for 4,564,997,687 units of the HYPERRAB 300 UNIT/ML VIAL 5ML product. The contract has an ultimate completion date of July 17, 2024 and was awarded on June 25, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is for the delivery of HYPERRAB 300 UNIT/ML VIAL 5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on December 10, 2024 with a completion date of January 2, 2025. The contract is a Delivery Order with a Firm Fixed Price of $4,656.64. The contract is not designated with a set-aside. AmerisourceBergen Drug Corp holds a larger $999,999,999 Indefinite...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $2,967.56 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the delivery of ENGERIX-B 20 MCG/ML SYRNML, a hepatitis B vaccine, to support military treatment programs and facilities. This delivery order contract is part of a larger indefinite delivery contract (IDC) awarded...